Enterovirus 71 Human
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Enterovirus 71 Human trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Enterovirus 71 Human trials you may qualify forThis study is designed to evaluate the long-term antibody titers of Envacgen® approximately 6 years after the first vaccination dose in participants who were ag…
This is a thirteen-year follow-up study conducted as an extension of a Phase III clinical trial. In this study, a sub-cohort of volunteers who was eligible for…
Enterovirus 71 (EV71), a major pathogen that is responsible for causing hand-foot-and-mouth disease (HFMD) worldwide, is a member of the Human Enterovirus speci…